UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15251) 15251
Newsletter (537) 537
Book Chapter (157) 157
Newspaper Article (75) 75
Magazine Article (63) 63
Dissertation (36) 36
Conference Proceeding (14) 14
Publication (10) 10
Web Resource (8) 8
Book / eBook (3) 3
Book Review (2) 2
Journal / eJournal (1) 1
Poster (1) 1
Reference (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infliximab (14523) 14523
humans (10442) 10442
science & technology (9359) 9359
life sciences & biomedicine (9227) 9227
antibodies, monoclonal - therapeutic use (5932) 5932
female (5794) 5794
male (5721) 5721
adult (4599) 4599
middle aged (4161) 4161
tumor necrosis factor-alpha - antagonists & inhibitors (4046) 4046
treatment outcome (3268) 3268
etanercept (3023) 3023
gastroenterology & hepatology (2738) 2738
adalimumab (2727) 2727
rheumatology (2533) 2533
antibodies, monoclonal - adverse effects (2479) 2479
antirheumatic agents - therapeutic use (2239) 2239
rheumatoid arthritis (2208) 2208
crohn disease - drug therapy (2178) 2178
monoclonal antibodies (2117) 2117
arthritis, rheumatoid - drug therapy (2076) 2076
aged (2061) 2061
crohn's disease (2007) 2007
tumor necrosis factor-α (1636) 1636
ulcerative colitis (1544) 1544
inflammatory bowel disease (1526) 1526
care and treatment (1511) 1511
infliximab - therapeutic use (1468) 1468
antibodies, monoclonal - administration & dosage (1439) 1439
adolescent (1381) 1381
drug therapy (1367) 1367
gastrointestinal agents - therapeutic use (1340) 1340
immunoglobulin g - therapeutic use (1316) 1316
receptors, tumor necrosis factor - therapeutic use (1307) 1307
patients (1300) 1300
anti-inflammatory agents - therapeutic use (1284) 1284
retrospective studies (1256) 1256
abridged index medicus (1236) 1236
young adult (1178) 1178
psoriasis (1167) 1167
dermatology (1150) 1150
severity of illness index (1124) 1124
immunosuppressive agents - therapeutic use (1117) 1117
drug therapy, combination (1061) 1061
research (1060) 1060
pharmacology & pharmacy (1048) 1048
tumor necrosis factor (1037) 1037
antirheumatic agents - adverse effects (1023) 1023
colitis, ulcerative - drug therapy (997) 997
medicine & public health (978) 978
arthritis (936) 936
antibodies, monoclonal, humanized (925) 925
follow-up studies (901) 901
risk factors (859) 859
tumor necrosis factor-tnf (847) 847
tumor necrosis factor-alpha - immunology (834) 834
child (795) 795
immunology (794) 794
methotrexate (790) 790
inflammatory bowel diseases - drug therapy (782) 782
psoriasis - drug therapy (777) 777
general & internal medicine (722) 722
medical research (722) 722
prospective studies (718) 718
time factors (713) 713
methotrexate - therapeutic use (711) 711
antibodies, monoclonal, humanized - therapeutic use (702) 702
dosage and administration (701) 701
medicine, general & internal (690) 690
remission induction (688) 688
animals (687) 687
health aspects (677) 677
analysis (675) 675
medicine, experimental (649) 649
ankylosing spondylitis (639) 639
anti-inflammatory agents, non-steroidal - therapeutic use (638) 638
antibodies, monoclonal - pharmacology (638) 638
inflammatory bowel diseases (636) 636
inflammation (595) 595
crohn disease - complications (564) 564
adalimumab - therapeutic use (559) 559
surgery (554) 554
spondylitis, ankylosing - drug therapy (548) 548
rheumatoid factor (544) 544
immunoglobulin g - adverse effects (539) 539
antirheumatic agents - administration & dosage (528) 528
clinical trials (521) 521
dermatologic agents - therapeutic use (517) 517
crohn’s disease (515) 515
gastrointestinal agents - adverse effects (509) 509
internal medicine (503) 503
anti-inflammatory agents - adverse effects (488) 488
infliximab - adverse effects (486) 486
pediatrics (485) 485
tumors (480) 480
drug administration schedule (474) 474
gastrointestinal diseases (461) 461
biological products (457) 457
infliximab - administration & dosage (447) 447
dose-response relationship, drug (443) 443
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14662) 14662
Spanish (352) 352
French (318) 318
Japanese (314) 314
German (238) 238
Portuguese (137) 137
Korean (136) 136
Russian (105) 105
Italian (85) 85
Polish (56) 56
Chinese (46) 46
Danish (38) 38
Hungarian (37) 37
Czech (34) 34
Dutch (28) 28
Turkish (24) 24
Slovak (12) 12
Croatian (11) 11
Hebrew (10) 10
Swedish (9) 9
Norwegian (8) 8
Finnish (5) 5
Persian (3) 3
Romanian (2) 2
Greek (1) 1
Icelandic (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of gastroenterology, ISSN 0944-1174, 3/2016, Volume 51, Issue 3, pp. 241 - 251
Journal Article
Journal Article
La revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, p. A163
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.10.116 Il... 
Infliximab
Journal Article
La revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, pp. A164 - A164
L’infliximab (IFX) est un biomédicament de la famille des anti-TNFa qui a révolutionné la prise en charge des maladies rhumatismales chroniques telles que la... 
Infliximab
Journal Article
The AAPS journal, ISSN 1550-7416, 1/2017, Volume 19, Issue 1, pp. 215 - 222
Journal Article
La revue de medecine interne, ISSN 0248-8663, 12/2016, Volume 37, p. A266-A267
L'infliximab est un anticorps monoclonal chimerique (humain-murin) qui a montre des effets therapeutiques spectaculaires chez les patients atteints de... 
Infliximab
Journal Article
Gut, ISSN 0017-5749, 10/2015, Volume 64, Issue 10, pp. 1539 - 1545
Journal Article